Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CD20 CAR-T cells |
Trade Name | |
Synonyms | anti-CD20 CAR|CD20 CAR T-cells|C-CAR066|CMB.CD20 CAR T C-CAR066 |
Drug Descriptions |
CD20 CAR-T cells are T-cells engineered to express a chimeric antigen receptor (CAR) targeting CD20, which potentially induce toxicity against CD20-expressing tumor cells and inhibit tumor growth (PMID: 25492700). |
DrugClasses | CD20 Immune Cell Therapy 11 |
CAS Registry Number | NA |
NCIT ID | C176772 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CD20 CAR-T cells | CD20 CAR-T cells | 0 | 0 |
CD20 CAR-T cells + Cyclophosphamide + Fludarabine | CD20 CAR-T cells Cyclophosphamide Fludarabine | 0 | 1 |